| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 380 |
| 1 | TADALAFIL | 164 |
| 2 | ORLISTAT | 111 |
| 3 | ALPRAZOLAM | 101 |
| 4 | BEVACIZUMAB | 70 |
| 5 | ORAL SEMAGLUTIDE | 69 |
| 6 | RIVAROXABAN | 67 |
| 7 | SILDENAFIL | 61 |
| 8 | ATORVASTATIN CALCIUM | 53 |
| 9 | OXYCODONE | 52 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVOBENZONE,HOMOSALATE,OCTINOXATE,OCTISALATE | 1 | 1.0000 |
| 1 | CHASTE TREE FRUIT | 1 | 0.0417 |
| 2 | BERACTANT | 7 | 0.0190 |
| 3 | ADEFOVIR DIPIVOXIL | 19 | 0.0149 |
| 4 | HUMAN RHO(D) IMMUNE GLOBULIN | 14 | 0.0136 |
| 5 | JOINT HEALTH CAPSULES | 1 | 0.0133 |
| 6 | IOBENGUANE I-123 | 1 | 0.0088 |
| 7 | METHSCOPOLAMINE BROMIDE | 1 | 0.0069 |
| 8 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0055 |
| 9 | TETRACAINE | 2 | 0.0051 |
| # | Drug class | Count |
|---|---|---|
| 0 | Phosphodiesterase 5 Inhibitor [EPC] | 196 |
| 1 | Benzodiazepine [EPC] | 181 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 159 |
| 3 | GLP-1 Receptor Agonist [EPC] | 128 |
| 4 | Intestinal Lipase Inhibitor [EPC] | 111 |
| 5 | Factor Xa Inhibitor [EPC] | 110 |
| 6 | Estrogen [EPC] | 85 |
| 7 | Opioid Agonist [EPC] | 76 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 75 |
| 9 | Acetylcholine Release Inhibitor [EPC] | 66 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Amino Acid Hypertonic Solution [EPC] | 1 | 0.0063 |
| 1 | Surfactant [EPC] | 7 | 0.0060 |
| 2 | Intestinal Lipase Inhibitor [EPC] | 111 | 0.0047 |
| 3 | Serotonin-4 Receptor Agonist [EPC] | 2 | 0.0030 |
| 4 | Opioid Antagonist [EPC] | 2 | 0.0021 |
| 5 | Human Immunoglobulin G [EPC] | 41 | 0.0019 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 196 | 0.0014 |
| 7 | Provitamin D2 Compound [EPC] | 41 | 0.0014 |
| 8 | Anthelmintic [EPC] | 4 | 0.0014 |
| 9 | Dopamine-2 Receptor Antagonist [EPC] | 10 | 0.0013 |